CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Grant or award Director acquired 495 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 200 shares at $185.00 ($37,000)
- 4 Shares withheld for taxes SVP - Novus Biologicals gave up 900 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,424 shares (to pay taxes)
- 4 Option exercise Chief Executive Officer acquired 24,979 shares (option exercise)
- 4 Shares withheld for taxes SVP - General Counsel gave up 745 shares (to pay taxes)
- 4 Option exercise Chief Executive Officer acquired 7,410 shares (option exercise)
- 4 Open-market buy Director bought 500 shares at $191.06 ($95,530)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 11,291 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 16,969 shares at an average $213.12 ($3,616,428)
Page 15 of 35 · 695 filings